109 results
Page 4 of 6
424B5
4igvvypst7o
5 Feb 21
Prospectus supplement for primary offering
5:26pm
424B5
8zobdblas 2ux7k
3 Feb 21
Prospectus supplement for primary offering
5:12pm
8-K
EX-2.1
59qjxi214mc1pp5
5 Jan 21
Entry into a Material Definitive Agreement
4:49pm
8-K
bb4yxd6nn51kcdx 8n
16 Sep 20
Departure of Directors or Certain Officers
4:01pm
8-K
pw7k ifctxbb9lm7t4
21 Jul 20
Entry into a Material Definitive Agreement
5:15pm
8-K
EX-10.1
jwsopwhqwpp77
21 Jul 20
Entry into a Material Definitive Agreement
5:15pm
8-K
EX-10.1
ei4z9
8 Jan 20
Rhythm Pharmaceuticals Announces Leadership Transition
4:00pm
8-K
EX-99.1
pndvrcz8
6 Nov 19
Rhythm Pharmaceuticals Announces Late-breaking Data from Phase 3 Trials of Setmelanotide in POMC and LEPR Deficiency Obesities at ObesityWeek 2019
9:28am
8-K
EX-1.1
75ov23edlyn8m4c4b540
16 Oct 19
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
5:27pm
424B5
8iv6 ccgej
16 Oct 19
Prospectus supplement for primary offering
5:25pm
424B5
es72zz10u8
15 Oct 19
Prospectus supplement for primary offering
4:51pm